Follow
Michael J Flister
Michael J Flister
Director, ADC Discovery Research at Pfizer Oncology
Verified email at pfizer.com - Homepage
Title
Cited by
Cited by
Year
Lymphangiogenesis and lymphatic metastasis in breast cancer
S Ran, L Volk, K Hall, MJ Flister
Pathophysiology 17 (4), 229-251, 2010
3222010
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1
MJ Flister, A Wilber, KL Hall, C Iwata, K Miyazono, RE Nisato, MS Pepper, ...
Blood, The Journal of the American Society of Hematology 115 (2), 418-429, 2010
2392010
Identifying multiple causative genes at a single GWAS locus
MJ Flister, SW Tsaih, CC O'Meara, B Endres, MJ Hoffman, AM Geurts, ...
Genome research 23 (12), 1996-2002, 2013
1262013
Vascular interventional radiology-guided photothermal therapy of colorectal cancer liver metastasis with theranostic gold nanorods
AK Parchur, G Sharma, JM Jagtap, VR Gogineni, PS LaViolette, MJ Flister, ...
ACS nano 12 (7), 6597-6611, 2018
1162018
Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model
B Whitehurst, MJ Flister, J Bagaitkar, L Volk, CM Bivens, B Pickett, ...
International Journal of Cancer 121 (10), 2181-2191, 2007
1152007
New model of macrophage acquisition of the lymphatic endothelial phenotype
KL Hall, LD Volk-Draper, MJ Flister, S Ran
PLoS One 7 (3), e31794, 2012
962012
Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases
LD Volk, MJ Flister, D Chihade, N Desai, V Trieu, S Ran
Neoplasia 13 (4), 327-IN14, 2011
892011
Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti–vascular endothelial growth factor A therapy
LD Volk, MJ Flister, CM Bivens, A Stutzman, N Desai, V Trieu, S Ran
Neoplasia 10 (6), 613-623, 2008
862008
Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity
NC Yeo, CC O’Meara, JA Bonomo, KN Veth, R Tomar, MJ Flister, ...
Genome research 25 (1), 57-65, 2015
792015
Mitochondrial oxidative phosphorylation defect in the heart of subjects with coronary artery disease
K Ait-Aissa, SC Blaszak, G Beutner, SW Tsaih, G Morgan, JH Santos, ...
Scientific reports 9 (1), 7623, 2019
772019
Genetic fine‐mapping and identification of candidate genes and variants for adiposity traits in outbred rats
GR Keele, JW Prokop, H He, K Holl, J Littrell, A Deal, S Francic, L Cui, ...
Obesity 26 (1), 213-222, 2018
732018
Mutation of Plekha7 attenuates salt-sensitive hypertension in the rat
BT Endres, JRC Priestley, O Palygin, MJ Flister, MJ Hoffman, ...
Proceedings of the National Academy of Sciences 111 (35), 12817-12822, 2014
662014
mTORC1 and mTORC2 differentially promote natural killer cell development
C Yang, SW Tsaih, A Lemke, MJ Flister, MS Thakar, S Malarkannan
Elife 7, e35619, 2018
632018
IL-13 promotes in vivo neonatal cardiomyocyte cell cycle activity and heart regeneration
DJ Wodsedalek, SJ Paddock, TC Wan, JA Auchampach, A Kenarsary, ...
American Journal of Physiology-Heart and Circulatory Physiology 316 (1), H24-H34, 2019
482019
Characterization of coding/noncoding variants for SHROOM3 in patients with CKD
JW Prokop, NC Yeo, C Ottmann, SB Chhetri, KL Florus, EJ Ross, ...
Journal of the American Society of Nephrology 29 (5), 1525-1535, 2018
482018
Mitochondria-targeted honokiol confers a striking inhibitory effect on lung cancer via inhibiting complex I activity
J Pan, Y Lee, G Cheng, J Zielonka, Q Zhang, M Bajzikova, D Xiong, ...
Iscience 3, 192-207, 2018
442018
Genetic variations in human papillomavirus and cervical cancer outcomes
JS Rader, SW Tsaih, D Fullin, MW Murray, M Iden, MT Zimmermann, ...
International journal of cancer 144 (9), 2206-2214, 2019
382019
The p52 isoform of SHC1 is a key driver of breast cancer initiation
KD Wright, BS Miller, S El-Meanawy, SW Tsaih, A Banerjee, AM Geurts, ...
Breast Cancer Research 21, 1-12, 2019
352019
Molecular profile and proliferative responses of rat lymphatic endothelial cells in culture
B Whitehurst, C Eversgerd, M Flister, CM Bivens, B Pickett, DC Zawieja, ...
Lymphatic Research and Biology 4 (3), 119-142, 2006
342006
Cellular reprogramming for successful CNS axon regeneration is driven by a temporally changing cast of transcription factors
SP Dhara, A Rau, MJ Flister, NM Recka, MD Laiosa, PL Auer, AJ Udvadia
Scientific reports 9 (1), 14198, 2019
312019
The system can't perform the operation now. Try again later.
Articles 1–20